SLN biopsy in breast cancer: Christiana care experience. May 1998-February 1999.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to D Dickson-Witmer.
Explore the source record for details and available documents.
BACKGROUND: Percutaneous stereotactic core biopsy has become an alternative to open surgical biopsy. STUDY: We report the initial 100 consecutive stereotactic core breast biopsies performed in a private breast center by three surgeons. RESULTS: Of the lesions biopsied, 89 were benign and 11 were malignant. Histological agreement was found in ten malignant and eight benign lesions that subsequently underwent open biopsy. In one patient with a lesion read as sclerosing papilloma on stereotactic core biopsy, a subsequent open biopsy undertaken at the pathologist's urging yielded a low-grade ductal carcinoma in situ. CONCLUSIONS: Stereotactic core breast biopsy is safe, accurate, cost-effective, and minimally invasive. It will, in all likelihood, become the breast biopsy method of choice.
Explore the source record for details and available documents.